Amag Pharmaceuticals boosts stock sale to 3.6M shares, offering priced at $48.25 per share

Amag Pharmaceuticals prices 3.6M stock offering

LEXINGTON, Mass. — Amag Pharmaceuticals Inc. said it priced a public offering of 3.6 million common shares at $48.25 per share.

The biopharmaceutical company said late Wednesday that the offering’s size had been increased by 600,000 shares.

Amag gave the underwriters an option to buy up to an additional 540,000 shares to cover any overallotments.

The offering is likely to close on Jan. 26.

Shares of Amag Pharmaceuticals closed Wednesday at $49.28.